BCB Bancorp, Inc. and BCB Community Bank Elect Raymond J. Vanaria to its Boards of Directors
BAYONNE, N.J., July 02, 2024 (GLOBE NEWSWIRE) — BCB Bancorp, Inc. (the “Company”), (NASDAQ: BCBP), the holding company for BCB […]
Atossa Therapeutics Appoints Heather Rees as Chief Financial Officer
SEATTLE, July 02, 2024 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced the appointment […]
Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024
RADNOR, Pa., July 02, 2024 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today […]
Compass Diversified Declares Second Quarter 2024 Distributions on Common and Series A, B and C Preferred Shares
WESTPORT, Conn., July 02, 2024 (GLOBE NEWSWIRE) — Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading […]
Employers Holdings, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call
HENDERSON, Nev., July 02, 2024 (GLOBE NEWSWIRE) — Employers Holdings, Inc. (the “Company”) (NYSE:EIG) today announced that it will release its […]
PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share
MIAMI, July 02, 2024 (GLOBE NEWSWIRE) — PennantPark Investment Corporation (the “Company”) (NYSE: PNNT) declares its monthly distribution for July […]
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024
— Recorded Fourth Quarter Revenue of $43.0 Million – Highest in Company History — — Signed $30 Million in Net […]
Cipher Mining Announces June 2024 Operational Update
NEW YORK, July 02, 2024 (GLOBE NEWSWIRE) — Cipher Mining Inc. (NASDAQ:CIFR) (“Cipher” or the “Company”) today released its unaudited […]
Exponent to Announce Second Quarter of Fiscal Year 2024 Results and Host Quarterly Conference Call on July 25, 2024
MENLO PARK, Calif., July 02, 2024 (GLOBE NEWSWIRE) — Exponent, Inc. (Nasdaq: EXPO), today announced that it will report Second […]
Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism
IRVINE, Calif., July 02, 2024 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that the Company’s management team […]
